DME · Ophthalmology · 4 drugs · 2 indications
| Drug | Company | Mechanism | Modality | Route | Stage |
|---|---|---|---|---|---|
| Lucentis | ROG.SW, NVS | VEGF antagonist | Antibody fragment | Intravitreal | APPROVED |
| Vabysmo | ROG.SW | Ang-2/VEGF-A dual targeting | Bispecific | Intravitreal | APPROVED |
| EYLEA | REGN | VEGF trap (fusion protein) | Fusion protein | Intravitreal | APPROVED |
| EYLEA HD | REGN | VEGF trap (fusion protein) | Fusion protein | Intravitreal | APPROVED |